These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16181226)

  • 1. Dry-heat sensitivity of human B19 and porcine parvoviruses.
    Prikhod'ko GG
    Transfusion; 2005 Oct; 45(10):1692-3. PubMed ID: 16181226
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetics of inactivating human parvovirus B19 and porcine parvovirus by dry-heat treatment.
    Blümel J; Stühler A; Dichtelmüller H
    Transfusion; 2008 Apr; 48(4):790. PubMed ID: 18366462
    [No Abstract]   [Full Text] [Related]  

  • 3. Variability of parvovirus B19 to inactivation by liquid heating in plasma products.
    Hattori S; Yunoki M; Tsujikawa M; Urayama T; Tachibana Y; Yamamoto I; Yamamoto S; Ikuta K
    Vox Sang; 2007 Feb; 92(2):121-4. PubMed ID: 17298573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of parvovirus B19 by liquid heating incorporated in the manufacturing process of human intravenous immunoglobulin preparations.
    Yunoki M; Urayama T; Tsujikawa M; Sasaki Y; Abe S; Takechi K; Ikuta K
    Br J Haematol; 2005 Feb; 128(3):401-4. PubMed ID: 15667545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of parvovirus B19 during pasteurization of human serum albumin.
    Blümel J; Schmidt I; Willkommen H; Löwer J
    Transfusion; 2002 Aug; 42(8):1011-8. PubMed ID: 12385412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of parvovirus B19 during STIM-4 vapor heat treatment of three coagulation factor concentrates.
    Berting A; Modrof J; Unger U; Gessner M; Klotz A; Poelsler G; Kreil TR
    Transfusion; 2008 Jun; 48(6):1220-6. PubMed ID: 18410254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the inactivation of canine and bovine parvovirus by freeze-drying and dry-heat treatment in two high purity factor VIII concentrates.
    Roberts PL; Hart H
    Biologicals; 2000 Sep; 28(3):185-8. PubMed ID: 10964445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dry-heat treatment process for enhancing viral safety of an antihemophilic factor VIII concentrate prepared from human plasma.
    Kim IS; Choi YW; Kang Y; Sung HM; Shin JS
    J Microbiol Biotechnol; 2008 May; 18(5):997-1003. PubMed ID: 18633304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of parvovirus B19 and model viruses in factor VIII by dry heat treatment at 80 degrees C.
    Roberts PL; El Hana C; Saldana J
    Transfusion; 2006 Sep; 46(9):1648-50; author reply 1650. PubMed ID: 16965597
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of manufacturing process parameters on virus inactivation by dry heat treatment at 80 degrees C in factor VIII.
    Roberts PL; Dunkerley C; McAuley A; Winkelman L
    Vox Sang; 2007 Jan; 92(1):56-63. PubMed ID: 17181591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism underlying B19 virus inactivation and comparison to other parvoviruses.
    Mani B; Gerber M; Lieby P; Boschetti N; Kempf C; Ros C
    Transfusion; 2007 Oct; 47(10):1765-74. PubMed ID: 17880601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell culture-based assay of parvovirus B19 and the relevance of animal model viruses.
    Blümel J
    Dev Biol (Basel); 2004; 118():107-12. PubMed ID: 15645679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B19 parvovirus withstands "super heating" in antihemophilic concentrates.
    Morfini M; Azzi A; Mannucci PM
    Thromb Haemost; 1996 Nov; 76(5):821. PubMed ID: 8950802
    [No Abstract]   [Full Text] [Related]  

  • 14. Parvovirus uncoating in vitro reveals a mechanism of DNA release without capsid disassembly and striking differences in encapsidated DNA stability.
    Ros C; Baltzer C; Mani B; Kempf C
    Virology; 2006 Feb; 345(1):137-47. PubMed ID: 16242744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of iatrogenic transmission of B19 infection: different approaches to detect, remove or inactivate virus contamination.
    Bonvicini F; Gallinella G; Gentilomi GA; Ambretti S; Musiani M; Zerbini M
    Clin Lab; 2006; 52(5-6):263-8. PubMed ID: 16812953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental endothelial cells can be productively infected by Parvovirus B19.
    Pasquinelli G; Bonvicini F; Foroni L; Salfi N; Gallinella G
    J Clin Virol; 2009 Jan; 44(1):33-8. PubMed ID: 19058999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time PCR protocol for the detection of porcine parvovirus in field samples.
    Wilhelm S; Zimmermann P; Selbitz HJ; Truyen U
    J Virol Methods; 2006 Jun; 134(1-2):257-60. PubMed ID: 16472875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination.
    Sawyer L; Hanson D; Castro G; Luckett W; Dubensky TW; Stassinopoulos A
    Transfusion; 2007 Jun; 47(6):1062-70. PubMed ID: 17524098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of porcine circovirus and chicken anemia virus to virus inactivation procedures used for blood products.
    Welch J; Bienek C; Gomperts E; Simmonds P
    Transfusion; 2006 Nov; 46(11):1951-8. PubMed ID: 17076851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Problems of contamination, exposure, and pollution in freeze-drying biological products.
    LaSalle B
    Dev Biol Stand; 1976 Oct; 36():201-5. PubMed ID: 1030420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.